In VitroActivity of Tigecycline, Tetracycline and Fluoroquinolones againstBrucella melitensis-Reference-Cited by-同舟云学术

In VitroActivity of Tigecycline, Tetracycline and Fluoroquinolones againstBrucella melitensis

Published:2008-02 Issue:1 Volume:20 Page:33-37
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Kilic S.,Dizbay M.,Cabadak H.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference31 articles.

1. Joint Food and Agriculture Organization/World Health Organization. FAO-WHO Expert Committee on brucellosis (sixth report). WHO Technical Report Series No. 740. Geneva: World Health Organisation; 1986: 56-57.

2. Brucellosis

3. New approaches to the antibiotic treatment of brucellosis

4. Recognition and Optimum Treatment of Brucellosis

5. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of Brucella melitensis and Brucella abortus Fluoroquinolones Resistant Isolates: A Systematic Review and Meta-Analysis;Vector-Borne and Zoonotic Diseases;2023-10-20

2. Prevalence of Brucella melitensis and Brucella abortus tetracyclines resistance: A systematic review and meta-analysis;Microbial Pathogenesis;2023-10

3. Antimicrobial resistance profiles of human Brucella melitensis isolates in three different microdilution broths: the first multicentre study in Bosnia and Herzegovina;Journal of Global Antimicrobial Resistance;2022-06

4. The perspective of antibiotic therapeutic challenges of brucellosis in the Middle East and North African countries: Current situation and therapeutic management;Transboundary and Emerging Diseases;2022-03-13

5. Brucellosis in transplant recipients: A systematic review;Transplant Infectious Disease;2021-03-27